Insider Transactions in Q1 2022 at Butterfly Network, Inc. (BFLY)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
Darius Shahida Chief Strategy/Bus Dev Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,280
+7.63%
|
-
|
|
Mar 22
2022
|
Troy Quander SVP, Regulatory and Quality |
BUY
Grant, award, or other acquisition
|
Direct |
34,866
+16.62%
|
-
|
|
Mar 22
2022
|
John David Martin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,789
+15.83%
|
-
|
|
Mar 22
2022
|
Stacey Pugh Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,713
+11.57%
|
-
|
|
Mar 22
2022
|
Andrei G Stoica Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,656
+16.26%
|
-
|
|
Mar 22
2022
|
Mary Miller General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
54,789
+12.5%
|
-
|
|
Mar 22
2022
|
Todd Fruchterman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
112,069
+6.82%
|
-
|
|
Mar 21
2022
|
Jonathan M Rothberg Director |
BUY
Other acquisition or disposition
|
Indirect |
6,202,545
+41.22%
|
-
|
|
Mar 21
2022
|
Jonathan M Rothberg Director |
SELL
Other acquisition or disposition
|
Indirect |
6,202,545
-38.96%
|
-
|
|
Mar 21
2022
|
Jonathan M Rothberg Director |
BUY
Other acquisition or disposition
|
Indirect |
6,202,545
+50.0%
|
-
|
|
Mar 21
2022
|
Jonathan M Rothberg Director |
SELL
Other acquisition or disposition
|
Indirect |
6,202,545
-100.0%
|
-
|
|
Mar 17
2022
|
Darius Shahida Chief Strategy/Bus Dev Officer |
SELL
Open market or private sale
|
Direct |
16,430
-2.52%
|
$82,150
$5.39 P/Share
|
|
Mar 17
2022
|
Stephanie Fielding Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,269
-2.81%
|
$16,345
$5.39 P/Share
|
|
Mar 15
2022
|
Larry Robbins |
BUY
Open market or private purchase
|
Indirect |
500,000
+8.38%
|
$2,000,000
$4.5 P/Share
|
|
Mar 11
2022
|
Larry Robbins |
SELL
Other acquisition or disposition
|
Indirect |
3,159,563
-30.75%
|
-
|
|
Mar 04
2022
|
Troy Quander SVP, Regulatory and Quality |
BUY
Grant, award, or other acquisition
|
Direct |
120,689
+46.3%
|
-
|
|
Mar 04
2022
|
Darius Shahida Chief Strategy/Bus Dev Officer |
BUY
Grant, award, or other acquisition
|
Direct |
198,275
+23.31%
|
-
|
|
Mar 04
2022
|
Andrei G Stoica Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
310,344
+45.47%
|
-
|
|
Mar 04
2022
|
Mary Miller General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
189,655
+36.59%
|
-
|
|
Mar 04
2022
|
Todd Fruchterman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
387,931
+21.47%
|
-
|
|
Mar 04
2022
|
Stacey Pugh Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
258,620
+34.26%
|
-
|
|
Mar 04
2022
|
John David Martin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
189,655
+44.5%
|
-
|
|
Feb 16
2022
|
Mary Miller General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
16,677
-10.71%
|
$83,385
$5.95 P/Share
|
|
Feb 16
2022
|
Stacey Pugh Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
16,122
-6.35%
|
$80,610
$5.95 P/Share
|
|
Feb 02
2022
|
Todd Fruchterman President and CEO |
SELL
Open market or private sale
|
Direct |
99,239
-8.78%
|
$496,195
$5.82 P/Share
|